![Peter Guenter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Guenter
Directeur/Bestuurslid bij
IPSEN
Vermogen: 14 300 $ op 31-05-2026
Profiel
Peter Guenter is currently Director at Ipsen SA since 2026, Director at Vicore Pharma Holding AB since 2026, and Director at the European Federation of Pharmaceutical Industries & Assns.
Formerly, Mr. Guenter was Chief Executive Officer & Director at Almirall SA from 2017 to 2020, Member-Management Board & CEO-Healthcare at Merck KGaA from 2021 to 2025, Chief Executive Officer at Merck Healthcare KGaA, Chairman-Supervisory Board at Sanofi-Aventis Deutschland GmbH, Independent Non-Executive Director at Lakefront Biotherapeutics from 2019 to 2025, EVP, General Manager-Diabetes & Cardiovascular at Sanofi from 2013 to 2017, and Executive Vice President at Smithkline Beecham.
Education includes graduation from Ghent University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2025 | 501 ( 0% ) | 14 300 $ | 31-05-2026 |
Actieve functies van Peter Guenter
| Bedrijven | Functie | Begin |
|---|---|---|
| IPSEN | Directeur/Bestuurslid | 28-01-2026 |
| VICORE PHARMA HOLDING AB | Directeur/Bestuurslid | 07-05-2026 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Directeur/Bestuurslid | - |
Eerdere bekende functies van Peter Guenter
| Bedrijven | Functie | Einde |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Directeur/Bestuurslid | 28-07-2025 |
| MERCK KGAA | Corporate Officer/Principal | 01-06-2025 |
| ALMIRALL, S.A. | Algemeen Directeur | 31-12-2020 |
| SANOFI | Corporate Officer/Principal | 01-08-2017 |
Merck Healthcare KGaA
 Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Algemeen Directeur | - |
Opleiding van Peter Guenter
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Almirall SA
 Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Health Technology |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Smithkline Beecham | |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Merck Healthcare KGaA
Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Health Technology |
